Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,930
-$1,593 QoQ
Shares Held
9,336
+48.1% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 44 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. JSPR ranks #388 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in JSPR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,930 9,336
2026-03-31 $5,523 6,305
2025-12-31 $2,088 1,141
2025-09-30 $2 1
2025-06-30 $20,795 3,747
2025-03-31 $10,698 2,488
2024-12-31 $33,245 1,555
2024-09-30 $13,072 695
2023-12-31 $8,792 11,144
2023-06-30 $12,873 9,397
2022-12-31 $6,201 12,839
2022-09-30 $10,795 13,682
2022-06-30 $8,899 4,611
2022-03-31 $4,810 1,355
2021-12-31 $22,874 2,914
2021-09-30 $91,857 8,953